JNBA Financial Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

JNBA Financial Advisors’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-800	Closed	-$17K	–	716
2022 Q3	$17K	Hold	800	–	–	﹤0.01%	401
2022 Q2	$17K	Hold	800	–	–	﹤0.01%	422
2022 Q1	$13K	Hold	800	–	–	﹤0.01%	474
2021 Q4	$16K	Hold	800	–	–	﹤0.01%	463
2021 Q3	$15K	Hold	800	–	–	﹤0.01%	467
2021 Q2	$22K	Hold	800	–	–	﹤0.01%	390
2021 Q1	$24K	Hold	800	–	–	﹤0.01%	371
2020 Q4	$23K	Hold	800	–	–	﹤0.01%	353
2020 Q3	$20K	Hold	800	–	–	﹤0.01%	347
2020 Q2	$14K	Hold	800	–	–	﹤0.01%	370
2020 Q1	$7K	Hold	800	–	–	﹤0.01%	422
2019 Q4	$11K	Hold	800	–	–	﹤0.01%	430
2019 Q3	$10K	Hold	800	–	–	﹤0.01%	413
2019 Q2	$20K	Hold	800	–	–	﹤0.01%	349
2019 Q1	$25K	Buy	+800	New	+$28.4K	0.01%	307

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JNBA Financial Advisors's CVET Position: Q4 2022 in Review

JNBA Financial Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 800 shares — an estimated $17K sold.

JNBA Financial Advisors first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $25K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

JNBA Financial Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
JNBA Financial Advisors sold 800 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $17K.
JNBA Financial Advisors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
JNBA Financial Advisors's Covetrus, Inc. Common Stock position peaked at $25K in Q1 2019.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on JNBA Financial Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.